The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on August 1, 2019, to stockholders of record at the close of business on July 5, 2019.
The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable September 3, 2019 to stockholders of record at the close of business on August 6, 2019.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global
biopharmaceutical company whose mission is to discover, develop and
deliver innovative medicines that help patients prevail over serious
diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190613005764/en/
Contacts:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com
